Free Trial

DRW Securities LLC Purchases New Holdings in Centene Co. (NYSE:CNC)

Centene logo with Medical background
Remove Ads

DRW Securities LLC acquired a new position in Centene Co. (NYSE:CNC - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 5,179 shares of the company's stock, valued at approximately $314,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Capital Advisors Ltd. LLC boosted its stake in shares of Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock valued at $25,000 after purchasing an additional 177 shares during the last quarter. Hurley Capital LLC bought a new stake in Centene in the 4th quarter valued at approximately $26,000. Rialto Wealth Management LLC bought a new stake in Centene during the 4th quarter worth about $30,000. OFI Invest Asset Management bought a new position in Centene in the fourth quarter valued at approximately $33,000. Finally, SRS Capital Advisors Inc. increased its stake in shares of Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock worth $38,000 after purchasing an additional 267 shares during the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.

Centene Price Performance

Shares of NYSE:CNC traded down $0.92 during mid-day trading on Monday, reaching $62.94. The stock had a trading volume of 3,113,182 shares, compared to its average volume of 4,695,224. The company has a market cap of $31.22 billion, a P/E ratio of 10.09, a price-to-earnings-growth ratio of 0.80 and a beta of 0.53. The business's 50 day moving average price is $59.49 and its 200 day moving average price is $61.65. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. Centene Co. has a 1 year low of $55.03 and a 1 year high of $80.59.

Remove Ads

Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company had revenue of $40.81 billion for the quarter, compared to analyst estimates of $38.78 billion. During the same quarter in the prior year, the firm posted $0.45 EPS. Centene's quarterly revenue was up 3.4% compared to the same quarter last year. Research analysts expect that Centene Co. will post 6.86 EPS for the current fiscal year.

Analysts Set New Price Targets

CNC has been the subject of a number of recent research reports. StockNews.com upgraded shares of Centene from a "buy" rating to a "strong-buy" rating in a research note on Friday. Wells Fargo & Company dropped their price target on Centene from $76.00 to $72.00 and set an "overweight" rating for the company in a research note on Friday, February 14th. Robert W. Baird boosted their price objective on shares of Centene from $66.00 to $71.00 in a research note on Tuesday, February 4th. Guggenheim assumed coverage on shares of Centene in a research note on Wednesday, April 9th. They set a "neutral" rating for the company. Finally, Jefferies Financial Group upgraded shares of Centene from an "underperform" rating to a "hold" rating and lifted their price objective for the company from $53.00 to $64.00 in a research note on Tuesday, April 8th. Seven research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Centene currently has a consensus rating of "Moderate Buy" and an average target price of $80.85.

View Our Latest Stock Analysis on CNC

Centene Company Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn how options trading can help you navigate market volatility, manage risk, and maximize returns with MarketBeat's "Unlock the Potential in Options Trading." Click the link below to have this special report delivered to your inbox.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Donald Trump Owns These 7 Stocks, Should You?

Donald Trump Owns These 7 Stocks, Should You?

He’s one of the most talked-about billionaires in the world—but when it comes to investing, Donald Trump’s stock picks are shockingly… low-key.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads